問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-04-01 - 2030-12-31
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2022-04-01 - 2028-02-28
Participate Sites5Sites
Recruiting5Sites
2022-02-01 - 2026-12-31
Participate Sites3Sites
Recruiting3Sites
2024-07-31 - 2029-01-31
2023-03-01 - 2027-04-30
Atherosclerotic Cardiovascular Disease
olpasiran (AMG 890)
Participate Sites10Sites
Recruiting9Sites
Terminated1Sites
Division of General Internal Medicine
2021-12-01 - 2026-11-30
Gastric Cancer
靜脈點滴注射劑
2023-01-19 - 2026-06-30
2019-05-02 - 2026-01-17
Recruiting10Sites
2021-07-09 - 2026-05-31
2023-07-01 - 2027-12-31
Participate Sites2Sites
Recruiting2Sites
全部
